Last modified on July 17, 2023, at 00:16

MRNA vaccine

An mRNA vaccine is a "messenger RNA," which is not really a vaccine at all. Initial examples are the Covid vaccines by Pfizer and Moderna. Traditional vaccines inject an inactive or weakened form of a virus into someone. An mRNA vaccine does not do that.

Instead, an mRNA vaccine causes the body to form a protein to imitate a part of the virus, such as COVID-19. Then the body's own cells display these new proteins to its own immune system. The mRNA is a strand of genetic code to be read by one's own DNA in order to generate specifically coded-for proteins. In the Covid vaccines, the code protein is a spike protein prevalent on the outer shell of the COVID-19 virus that causes the disease.

The mRNA itself is wrapped in lipid nanoparticles to help preserve it after injection. The goal is for the recipient's immune cells to recognize and react by ultimately generating an immune response when exposed to the virus.

The stated purpose of an mRNA vaccine is to reprogram the body's immune system such that it immediately recognizes a particular new virus, such as COVID-19, and has encoded instructions how to fight against it in order to avoid a severe reaction to it.

Afterwards the mRNA is supposed to degrade and disappear in the body, supposedly within 48 hours of injection.

More mRNA vaccines

Big Pharma and liberals have an agenda of mandating a long list of additional mRNAs on the public: "Malaria, HIV, tuberculosis, and Zika are just some of the potential targets."[1]

Nearly half the public never fully accepted these mRNA vaccines, and many suspect lingering harm from them. Some seek mRNA-free blood transfusions. But liberals will continue to impose these mRNA vaccines in all their forms, wherever they can. This could be the biggest issue of the 2020s, and could impact the 2024 presidential election.

As of January 16, 2023, there are 37 written decisions referring to an "mRNA vaccine," even though the term is an oxymoron. Only 2 of those decisions were in state court, while 35 of them were in federal court.

A district court within the Tenth Circuit rejected a challenge to this vaccine by overrelying on the CDC as follows:

Plaintiffs' attempts to circumvent Jacobson are unavailing. Plaintiffs characterize the COVID-19 vaccines as "gene modification therapies," Doc. 20 at 10, but provide no medical authority to distinguish the COVID-19 mRNA vaccines from any other vaccines; indeed, public health information is to the contrary, as "the CDC has clearly opined that the [vaccines against COVID-19] constitute 'vaccines.'" Messina v. College of New Jersey, 566 F. Supp. 3d. 236, 248 (D.N.J. 2021); accord, Smith v. Biden, 21-cv-19457, 2021 U.S. Dist. LEXIS 215437, 2021 WL 5195688, at *6 (D.N.J. Nov. 8, 2021) (rejecting argument that Jacobson does not apply because "the COVID-19 vaccines are not actual vaccines"); Johnson, 567 F. Supp. 3d at 1249 (rejecting argument that Jacobson and the cases following it are irrelevant "because they either were not considering an 'experimental' vaccine or did not properly consider that the vaccine was not yet approved by the FDA," as such facts are not "dispositive on the standard of review"). In response to the specific question, "Is the mRNA vaccine considered a vaccine?" the CDC states: "Yes. mRNA vaccines, such as Pfizer-BioNTech and Moderna, work differently than other types of vaccines, but they [*40] still trigger an immune response inside your body. This type of vaccine is new, but research and development on it has been under way for decades." Messina, 566 F. Supp. 3d. at 248 (quoting Centers for Disease Control and Prevention, "Myths and Facts about COVID-19 Vaccines"). And as described above, "other courts — including this one — [have] reviewed similar challenges to COVID-19 vaccine policies and have uniformly concluded that Jacobson controls." Id.; see Legaretta v. Macias, F. Supp. 3d , 2022 U.S. Dist. LEXIS 82330, 2022 WL 1443014, at *11 (D.N.M. May 6, 2022).

Valdez v. Grisham, No. 21-cv-783 MV/JHR, 2022 U.S. Dist. LEXIS 148815, at *21 (D.N.M. Aug. 19, 2022).

Pfizer compared with Moderna

Both these vaccines are made using the messenger RNA platform. In adults, their initial efficacy estimates were virtually identical — 95% for Pfizer’s vaccine, 94% for Moderna’s. They were issued emergency use authorizations by the Food and Drug Administration within a week of each other in the United States in December 2020.[2]

See also